BUFFALO, NY – December 16, 2022, Garwood Medical Devices, LLC has been selected as an awardee of the Innovations for Vets Quickfire Challenge launched by Johnson & Johnson Innovation – JLABS with the Johnson & Johnson Office of Military and Veterans Affairs.
The intention behind this challenge was to help advance innovation that could benefit the military community. As a company named after veterans, Garwood Medical Devices, LLC plans to use BioPrax™ to benefit all prosthetic joint infection patients, especially those who have served.
BioPrax™ was granted FDA Breakthrough Device Designation in 2019 for our first indication, treatment of knee implant infection. Better than the two-stage revision, BioPrax™ is a single surgery solution used alongside a washout procedure with debridement (DAIR).BioPrax™ not only has the potential to improve patient outcomes but also reduce the economic burden of prosthetic joint infection. Additionally, BioPrax™ has the potential for both treatment and prevention of infection on virtually all metallic implants.